Safety and efficacy of long term asfotase alfa treatment in childhood hypophosphatasia
Abstract Background Hypophosphatasia (HPP) is a rare inherited disorder characterized by a deficiency of tissue-non-specific alkaline phosphatase (TNSALP) due to loss-of-function variants of the ALPL gene. HPP is characterized by an extremely variable age of onset and clinical presentation, largely...
Saved in:
| Main Authors: | Debora Mariarita d’Angelo, Federico Lauriola, Luisa Silvestrini, Luigia Cinque, Marco Castori, Giulia Di Donato, Armando Di Ludovico, Saverio La Bella, Francesco Chiarelli, Cosimo Giannini, Luciana Breda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Italian Journal of Pediatrics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13052-025-01883-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and safety of asfotase alfa for people with hypophosphatasia: a plain language summary of three studies
by: Fatma Al Jasmi, et al.
Published: (2025-03-01) -
Effects of asfotase alfa on fracture healing of adult patient with hypophosphatasia and literature review
by: Songqi Wang, et al.
Published: (2025-04-01) -
Efficacy of asfotase alfa in a patient with adult-onset hypophosphatasia without obvious bone lesions: a case report with review of literature
by: Seiji Nishikage, et al.
Published: (2025-04-01) -
Case Report: Suboptimal response to standard-dose asfotase alfa in perinatal hypophosphatasia indicates a need for individualized dosing
by: Danijela Petković Ramadža, et al.
Published: (2025-06-01) -
Pain, quality of life, and integral management in a cohort of patients diagnosed with hypophosphatasia in Colombia
by: Jorge Armando Rojas Martínez, et al.
Published: (2024-11-01)